证券代码：603707 证券简称：健友股份 公告编号：2025-078 南京健友生化制药股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 11 月 12 日 14 点 00 分 召开地点：南京市高新开发区学府路 16 号公司会议室 股东大会召开日期：2025年11月12日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (一)股东大会类型和届次 2025年第一次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 11 月 12 日 至2025 年 11 月 12 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当 ...

| 证券代码：603707 | 证券简称：健友股份 | 公告编号：2025-075 | | --- | --- | --- | | 债券代码：113579 | 债券简称：健友转债 | | 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 南京健友生化制药股份有限公司（以下简称"公司"或"本公司"）第五届 监事会第十一次会议的通知已于 2025 年 10 月 15 日以电话及电子邮件的方式向 各位监事发出，会议于 2025 年 10 月 24 日上午 10 点在公司会议室召开。会议应 到监事 3 人，实到监事 2 人。监事王慧梅女士因个人原因无法出席，委托监事刘 祖清代为出席并投票表决。 会议由监事会主席刘祖清先生主持。本次会议召集、召开符合《中华人民共 和国公司法》及有关法律、法规和《公司章程》的规定。会议审议并通过了如下 议案： 二、监事会会议审议情况 会议审议并通过了如下议案： （一）审议通过了《关于公司 2025 年三季度报告的议案》 全体监事保证 2025 年三季度报告所载不存在任何虚假性记 ...

| 证券代码：603707 | 证券简称：健友股份 | 公告编号：2025-074 | | --- | --- | --- | | 债券代码：113579 | 债券简称：健友转债 | | 南京健友生化制药股份有限公司 第五届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 南京健友生化制药股份有限公司（以下简称"公司"）第五届董事会第十五 次会议的通知已于 2025 年 10 月 15 日以电话及电子邮件的方式向各位董事发出， 会议于 2025 年 10 月 24 日上午 9 点整在公司会议室召开。会议应到董事 6 人， 实到董事 5 人，其中独立董事 1 人。独立董事金毅先生因个人原因无法出席，委 托独立董事崔国庆先生代为出席并投票表决。 本次会议由董事长唐咏群先生主持。本次会议召集、召开符合《中华人民共 和国公司法》及有关法律、法规和《公司章程》的规定。 二、董事会会议审议情况 会议审议并通过了如下议案： （一）审议通过了《关于公司 2025 年三季度报告的议案》 本 ...

Financial Performance - The company's operating revenue for the third quarter was CNY 945,898,414, representing a year-on-year increase of 0.06%[4] - The total profit for the quarter was CNY 151,928,051.88, a decrease of 38.56% compared to the same period last year[4] - The net profit attributable to shareholders was CNY 143,199,605.86, down 28.67% year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 123,973,705.84, reflecting a decrease of 30.95% compared to the previous year[4] - The basic earnings per share for the quarter was CNY 0.09, down 25.00% year-on-year[5] - Total revenue for the first three quarters of 2025 was CNY 2,925,743,881.48, a decrease of 5.3% compared to CNY 3,088,009,007.42 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 429,455,986.44, down 29.1% from CNY 605,775,481.17 in the previous year[19] - The company reported a total comprehensive income of CNY 429,971,758.03, down from CNY 613,080,783.94 in the previous year[20] - Basic earnings per share decreased to CNY 0.27 from CNY 0.37, a decline of 27.0%[20] Cash Flow and Assets - The cash flow from operating activities for the year-to-date was CNY 900,324,655.05, a decline of 14.67% compared to the same period last year[5] - The company reported cash and cash equivalents of ¥1,447,642,112.17 as of September 30, 2025, an increase from ¥1,024,384,215.58 on December 31, 2024, representing a growth of approximately 41.3%[14] - The total current assets amounted to ¥7,530,416,166.22 as of September 30, 2025, compared to ¥7,045,889,981.21 at the end of 2024, indicating an increase of about 6.9%[15] - Non-current assets totaled ¥2,777,039,115.22 as of September 30, 2025, up from ¥2,464,060,382.73, marking an increase of approximately 12.7%[15] - The ending balance of cash and cash equivalents increased to ¥1,315,566,941.98 from ¥626,536,891.47, marking a significant rise of 110.0%[24] Shareholder Information - The company reported a total of 29,213 ordinary shareholders at the end of the reporting period[11] - The company has a significant shareholder structure, with the largest shareholder, Xie Juhua, holding 27.21% of shares, followed by Jiangsu Coastal Development Group with 21.3%[12] - Tang Yongqun, an overseas individual shareholder, holds 19.8% of shares, with 42,841,500 shares pledged[12] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending activities[13] Operational Insights - The decline in profit was primarily due to reduced selling prices of certain products and an increase in period expenses[9] - The company has not reported any significant operational issues during the reporting period[14] - The company continues to focus on expanding its market presence and enhancing its product offerings through ongoing research and development efforts[14] - Research and development expenses rose to CNY 260,994,913.06, an increase of 20.7% compared to CNY 216,228,047.16 in 2024[19] Liabilities and Costs - Total operating costs increased to CNY 2,589,795,987.83, up 6.6% from CNY 2,430,007,182.20 year-over-year[18] - Total liabilities rose to CNY 3,556,274,956.94, up from CNY 3,021,793,728.13, marking an increase of 17.7%[16]

Core Insights - As of October 22, a total of 91 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stock with the longest streak of net buying is Jianyou Co., which has seen net purchases for 13 consecutive trading days [1] - Other notable stocks with significant net buying days include Yongmaotai, Jingwei Hengrun, Shengquan Group, Zhongwen Media, Yibin Paper, Baofeng Energy, Hanghua Co., and Donghua Testing [1]

Core Viewpoint - As of October 21, a total of 82 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the longest consecutive net buying days is Jianyou Co., which has seen net buying for 12 consecutive trading days [1] - Other notable stocks with significant net buying days include Jingwei Hengrun, Yongmaotai, Baihe Co., ST Chuangyi, Zhongwen Media, Renfu Pharmaceutical, Ruimaite, and Chenguang Co. [1]

Core Insights - The article discusses the phenomenon of continuous net buying by institutional investors in certain stocks, highlighting the disparity between retail and institutional investor behavior [1][3][7] - It emphasizes the importance of understanding the underlying data behind stock movements, particularly the "institutional inventory" data, to differentiate between sustainable growth and temporary spikes [5][7][8] Group 1: Market Behavior - The current market is characterized as a "liquidity bull market," where retail investors often react too late to market movements, leading to missed opportunities and losses [3][7] - The article draws a parallel to the quote from Qian Zhongshu's "Fortress Besieged," illustrating the conflicting desires of investors inside and outside the market [3] Group 2: Institutional vs. Retail Investors - Retail investors tend to enter the market after institutional investors have already made their moves, resulting in a detrimental time lag that can lead to significant losses [3][7] - The analysis of two contrasting stocks reveals that while one stock had a strong rebound, it lacked institutional support, indicating a potential trap for retail investors [5][7] Group 3: Stock Analysis - The article highlights 84 stocks that have seen continuous net buying from major funds, questioning whether this buying behavior is part of a strategic long-term investment or a short-term tactical move [7] - Historical data shows that stocks with a sustained upward trend in "institutional inventory" are more likely to experience long-term growth, while those with erratic inventory patterns may only see temporary gains [7] Group 4: Earnings Reports and Market Expectations - As the third-quarter earnings reports approach, the focus will shift to performance expectations, with "expectation gaps" being more critical than the earnings figures themselves [7] - The article suggests that monitoring changes in "institutional inventory" around earnings announcements can provide insights into whether institutions are selling on good news or buying into the stock [7][8]

Core Insights - As of October 16, a total of 78 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stocks with the longest streak of net buying are Kaisheng Technology, Wanxin Media, Jianyou Co., and Jinling Hotel, each having received net buying for nine consecutive trading days [1] - Other notable stocks with significant net buying days include Tiancheng Technology, China Electric Research, Junpu Intelligent, Hangxin Technology, Dongpeng Holdings, Shandong Publishing, Tongkun Co., and Yuanfang Information [1]

| 证券代码：603707 | | --- | | 证券简称：健友股份 公告编号：2025-073 | 本次回购资金总额不低于人民币 2,000 万元（含）且不超过人民币 4,000 万 元（含），本次回购股份的价格不超过 18.75 元/股（含），本次回购的股份用于 员工持股计划或股权激励，回购股份实施期限为自公司股东大会审议通过本次回 购股份方案之日起 12 个月内。具体内容详见公司于 2025 年 4 月 29 日披露的《健 友股份关于以集中竞价交易方式回购股份的预案》（公告编号：2025-028）。 二、回购股份的进展情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/29，由董事长唐咏群先生提议 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2025 年 月 20 5 | 5 | 日~2026 | 年 | 月 | 19 日 | | 预计回购金额 | 2,000万元~4 ...

| 证券代码：603707 | 证券简称：健友股份 | 公告编号：2025-072 | | --- | --- | --- | | 债券代码：113579 | 债券简称：健友转债 | | 南京健友生化制药股份有限公司 关于"健友转债"转股结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 转股情况： 截至 2025 年 9 月 30 日，累计已有人民币 719,000 元"健友转债"转为公司 普通股，累计回售人民币 7,000 元"健友转债"。"健友转债"累计转股股数 18,035 股，占转股前公司股份总额的 0.001%。 未转股可转债情况： 截至 2025 年 9 月 30 日，尚未转股的"健友转债"金额为人民币 502,464,000 元，占"健友转债"发行总量的比例为 99.86%。 一、可转债的发行上市概况 经中国证券监督管理委员会《关于核准南京健友生化制药股份有限公司公开 发行可转换公司债券的批复》（证监许可[2020]603 号）核准，南京健友生化制 药股份有限公司（以下简 ...